<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2019-1-113-121</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-997</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Регенеративная медицина и клеточные технологии</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Regenerative Medicine and Cell Technologies</subject></subj-group></article-categories><title-group><article-title>Сравнительный анализ эффективности стимуляции процессов регенерации печени клетками костного мозга и общей РНК этих клеток</article-title><trans-title-group xml:lang="en"><trans-title>The comparative analysis of the effectiveness of stimulation of liver regeneration by bone marrow cells and total RNA of these cells</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гоникова</surname><given-names>З. З.</given-names></name><name name-style="western" xml:lang="en"><surname>Gonikova</surname><given-names>Z. Z.</given-names></name></name-alternatives><bio xml:lang="ru"><p>123182, Москва, ул. Щукинская, д. 1.Тел. (966) 188-33-33. </p></bio><bio xml:lang="en"><p>1, Shchukinskaya str., Moscow, 123182.Теl. (966) 188-33-33.</p></bio><email xlink:type="simple">zalina3392@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никольская</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolskaya</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кирсанова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirsanova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шагидулин</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shagidulin</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Онищенко</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Onishchenko</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Севастьянов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sevastianov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>17</day><month>05</month><year>2019</year></pub-date><volume>21</volume><issue>1</issue><fpage>113</fpage><lpage>121</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гоникова З.З., Никольская А.О., Кирсанова Л.А., Шагидулин М.Ю., Онищенко Н.А., Севастьянов В.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Гоникова З.З., Никольская А.О., Кирсанова Л.А., Шагидулин М.Ю., Онищенко Н.А., Севастьянов В.И.</copyright-holder><copyright-holder xml:lang="en">Gonikova Z.Z., Nikolskaya A.O., Kirsanova L.A., Shagidulin M.Y., Onishchenko N.A., Sevastianov V.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/997">https://journal.transpl.ru/vtio/article/view/997</self-uri><abstract><p>Обширная резекция печени (ОРП), выполняемая при ряде хирургических операций, относится к критической травме, что обусловливает необходимость совершенствования методов терапии острой пострезекционной печеночной недостаточности.</p><sec><title>Цель</title><p>Цель: сравнить эффективность стимуляции восстановительных процессов в резецированной (на 60–70%) печени путем внутрибрюшинного введения лизированного аспирата клеток костного мозга (ККМ) и общей РНК, выделенной из ККМ (оРНК).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Работа выполнена на 175 крысах-самцах породы Вистар 250–300 г, у 75 из которых под ингаляционным наркозом воспроизводили модель ОРП в трех группах опытов: группа 1 – контрольная (введение физиологического раствора), группа 2 – через 3–5 часов после ОРП внутрибрюшинно вводили оРНК в дозе 30 мкг/100 г веса животного, группа 3 – через 3–5 часов после ОРП внутрибрюшинно вводили ККМ в дозе 30–35 × 106 клеток на крысу. Сравнительное исследование восстановительных процессов в печени после ОРП в трех группах осуществляли путем динамического контроля митотической активности гепатоцитов в печени, ферментов цитолиза и общего белка в сыворотке крови, а также массы печени.</p></sec><sec><title>Результаты</title><p>Результаты. Введение оРНК и ККМ в указанных дозах предотвращают опасность развития летальных исходов, а также способствуют более ранней (к 10–14-м суткам) нормализации функциональных показателей печеночного гомеостаза. Однако оРНК по сравнению с ККМ обладает более сильным стимулирующим воздействием на восстановительные процессы: способствует более ранней интенсификации митотической активности гепатоцитов и обеспечивает более высокий темп восстановления массы печени.</p></sec><sec><title>Заключение</title><p>Заключение. Для стимуляции восстановительных процессов в резецированной печени предпочтительно использовать оРНК.</p></sec></abstract><trans-abstract xml:lang="en"><p>Extensive liver resection (ELR), performed in a number of surgical operations, refers to a critical injury, which necessitates the improvement of methods of therapy of acute post-resection liver failure.</p><sec><title>Aim</title><p>Aim: to compare the effectiveness of stimulation of regenerative processes in the liver residue after ELR (60–70%) by intraperitoneal administration of lysed aspirate bone marrow cells (BMCs) and total RNA (tRNA) isolated from BMCs.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. This work was performed on 175 rats-male Wistar breed 250–300 g, on 75 of which under the inhalation anesthesia it was reproduced the model of the ELR in three groups of experiments: group 1 – control (administration of isotonic solution after ELR), group 2 – in 3–5 hours after ELR the tRNA from BMCs was intraperitoneally injected at a dose of 30 μg/100 g, group 3 – in 3–5 hours after ELR BMCs was administered intraperitoneally at a dose of 30–35 × 106 cells per rat. Comparative studies of the restorative processes in the liver after the ELR in the three groups were carried out by dynamic control of the mitotic activity of hepatocytes in the liver residue, cytolytic enzymes, total bilirubin and total serum protein, as well as the liver residue (mass) weight.</p></sec><sec><title>Results</title><p>Results. The tRNA from BMCs and BMCs in the indicated doses prevent the risk of the development of lethal outcomes, and also contribute to an earlier (by 10–14 days) normalization of the functional indices of hepatic homeostasis. However, the tRNA from BMCs, compared with BMCs, has a stronger stimulating effect on the recovery processes: it promotes earlier intensification of mitotic activity of hepatocytes and provides a higher rate of recovery of liver mass.</p></sec><sec><title>Conclusion</title><p>Conclusion. For the induction of recovery processes in the liver residue after ELR, the preference should be given to the tRNA from BMCs.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>обширная резекция печени</kwd><kwd>острая печеночная недостаточность</kwd><kwd>общая РНК</kwd><kwd>клетки костного мозга</kwd><kwd>регенерация печени</kwd></kwd-group><kwd-group xml:lang="en"><kwd>extensive liver resection</kwd><kwd>acute liver failure</kwd><kwd>total RNA</kwd><kwd>bone marrow cells</kwd><kwd>liver regeneration</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kawamura T, Noji T, Okamura K et al. Postoperative Liver Failure: Criteria for Predicting Mortality after Major Hepatectomy with Extrahepatic Bile Duct Resection. Dig Surg. 2018 Feb; 8. doi: 10.1159/000486906.</mixed-citation><mixed-citation xml:lang="en">Kawamura T, Noji T, Okamura K et al. Postoperative Liver Failure: Criteria for Predicting Mortality after Major Hepatectomy with Extrahepatic Bile Duct Resection. Dig Surg. 2018 Feb; 8. doi: 10.1159/000486906.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Khan AS, Garcia-Aroz S, Ansari MA et al. Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative review. Int J Surg. 2018 Apr; 52: 74–81.</mixed-citation><mixed-citation xml:lang="en">Khan AS, Garcia-Aroz S, Ansari MA et al. Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative review. Int J Surg. 2018 Apr; 52: 74–81.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005; 5 (11): 2605–2610.</mixed-citation><mixed-citation xml:lang="en">Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005; 5 (11): 2605–2610.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Котельникова ЛП, Будянская ИМ. Профилактика и лечение осложнений после резекции печени. Вестник хирургии им. И.И. Грекова. 2012; 171 (3): 67–71.</mixed-citation><mixed-citation xml:lang="en">Kotel’nikova LP, Budyanskaya IM. Prevention and treatment of complications after liver resection. Vestnik hirurgii im. I.I. Grekova. 2012; 171 (3): 67–71.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Panis Y, McMullan DM, Emond JC.Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery. 1997; 121: 142–149.</mixed-citation><mixed-citation xml:lang="en">Panis Y, McMullan DM, Emond JC. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery. 1997; 121: 142–149.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ельчанинов АВ. Молекулярные и клеточные механизмы регенерации печени после субтотальной резекции в эксперименте: автореф. дис. … докт. мед. наук. М., 2017. 41 с.</mixed-citation><mixed-citation xml:lang="en">El’chaninov AV. Molecular and cellular mechanisms of liver regeneration after Subtotal resec-tion in experiment: autoref. dis. … doct. med. nauk. M., 2017. 41 p.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Vivarelli M, Vincenzi P, Montalti R, Fava G, Tavio M, Coletta M et al. ALPPS Procedure for Extended Liver Resections: A Single Centre Experience and a Systematic Review. PLoS One. 2015; 10 (12): 23.</mixed-citation><mixed-citation xml:lang="en">Vivarelli M, Vincenzi P, Montalti R, Fava G, Tavio M, Coletta M et al. ALPPS Procedure for Extended Liver Resections: A Single Centre Experience and a Systematic Review. PLoS One. 2015; 10 (12): 23.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mahnken AH. Current status of transarterial radioembolization. World J Radiol. 2016; 8 (5): 449–459.</mixed-citation><mixed-citation xml:lang="en">Mahnken AH. Current status of transarterial radioembolization. World J Radiol. 2016; 8 (5): 449–459.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Nardo B, Vaccarisi S, Pellegrino V, Cannistra M, Barcellona E, Cavallari G. Extracorporeal portal vein arterialization in man after extended hepatectomy to prevent acute liver failure: a case report. Transplant Proc. 2011; 43 (4): 1193–1195.</mixed-citation><mixed-citation xml:lang="en">Nardo B, Vaccarisi S, Pellegrino V, Cannistra M, Barcellona E, Cavallari G. Extracorporeal portal vein arterialization in man after extended hepatectomy to prevent acute liver failure: a case report. Transplant Proc. 2011; 43 (4): 1193–1195.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Karvellas CJ, Subramanian RM. Current Evidence for Extracorporeal Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure. Crit Care Clin. 2016; 32 (3): 439–451.</mixed-citation><mixed-citation xml:lang="en">Karvellas CJ, Subramanian RM. Current Evidence for Extracorporeal Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure. Crit Care Clin. 2016; 32 (3): 439–451.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Baretta GA, Gama Filho O, Toderke EL, Tolazzi AR, Matias JE. Effect of cyclosporine on liver regeneration in partial hepatectomized rats. Acta Cir Bras. 2015; 30 (1): 54–59.</mixed-citation><mixed-citation xml:lang="en">Baretta GA, Gama Filho O, Toderke EL, Tolazzi AR, Matias JE. Effect of cyclosporine on liver regeneration in partial hepatectomized rats. Acta Cir Bras. 2015; 30 (1): 54–59.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">D’Espessailles A, Dossi C, Intriago G, Leiva P, Romanque P. Hormonal pretreatment presrvs liver regenerative capacity and minimizes inflamation after partial hepatectomy. Annals of hepatology. 2013; 12 (6): 981–991.</mixed-citation><mixed-citation xml:lang="en">D’Espessailles A, Dossi C, Intriago G, Leiva P, Romanque P. Hormonal pretreatment presrvs liver regenerative capacity and minimizes inflamation after partial hepatectomy. Annals of hepatology. 2013; 12 (6): 981–991.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hu C, Shen S, Zhang A, Ren B, Lin F. The liver protective effect of methylprednisolone on a new experimental acute-on-chronic liver failure model in rats. Dig Liver Dis. 2014; 6 (10): 928–935.</mixed-citation><mixed-citation xml:lang="en">Hu C, Shen S, Zhang A, Ren B, Lin F. The liver protective effect of methylprednisolone on a new experimental acute-on-chronic liver failure model in rats. Dig Liver Dis. 2014; 6 (10): 928–935.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Inokuma T, Yamanouchi K, Tomonaga T, Miyazaki K, Hamasaki K, Hidaka M et al. Curcumin improves the survival rate after a massive hepatectomy in rats. Hepatogastroenterology. 2012; 59 (119): 2243–2247.</mixed-citation><mixed-citation xml:lang="en">Inokuma T, Yamanouchi K, Tomonaga T, Miyazaki K, Hamasaki K, Hidaka M et al. Curcumin improves the survival rate after a massive hepatectomy in rats. Hepatogastroenterology. 2012; 59 (119): 2243–2247.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Qiu YD, Wang S, Yang Y, Yan XP. Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats. World J Gastroenterol. 2012; 18 (25): 3288–3295.</mixed-citation><mixed-citation xml:lang="en">Qiu YD, Wang S, Yang Y, Yan XP. Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats. World J Gastroenterol. 2012; 18 (25): 3288–3295.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sato T, Yasui O, Kurokawa T, Asanuma Y, Koyama K. Appraisal of intra-arterial infusion of prostaglandin E1 in patients undergoing major hepatic resection report of four case. Tohoku J Exp Med. 2001; 195 (2): 125–133.</mixed-citation><mixed-citation xml:lang="en">Sato T, Yasui O, Kurokawa T, Asanuma Y, Koyama K. Appraisal of intra-arterial infusion of prostaglandin E1 in patients undergoing major hepatic resection report of four case. Tohoku J Exp Med. 2001; 195 (2): 125–133.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Гальперин ЭИ, Дюжева ТГ, Платонова ЛВ и др. Уменьшение повреждения печени при ее обширной резекции и токсическом поражении. Анналы хирурги-ческой гепатологии. 2008; 13 (1): 51–55.</mixed-citation><mixed-citation xml:lang="en">Gal’perin EI, Dyuzheva TG, Platonova LV et al. Reduction of liver damage in its extensive resection and toxic damage. Annaly hirurgicheskoj gepatologii. 2008; 13 (1): 51–55.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Shagidulin M, Onishchenko N, Krasheninnikov M et al. Transplantation liver cells and multipotent mesenchymal stromal cells for correction and treatment of hepatic failure. Medimond International Proceedings. 2010: 83–86.</mixed-citation><mixed-citation xml:lang="en">Shagidulin M, Onishchenko N, Krasheninnikov M et al. Transplantation liver cells and multipotent mesenchymal stromal cells for correction and treatment of hepatic failure. Medimond International Proceedings. 2010: 83–86.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Бойко НВ, Голиков АЮ, Тарасов ВА, Матишов ДГ. Роль микро-РНК в регуляции активности генов у эукариот. Вестник южного научного центра РАН. 2011; 7 (3): 69–78.</mixed-citation><mixed-citation xml:lang="en">Boyko NV, Golikov AYu, Tarasov VA, Matishov DG. Role of microRNA in regulation of gene activity in eukaryotes. Vestnik yuzhnogo nauchnogo centra RAN. 2011; 7 (3): 69–78.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Prasanth KV, Spector DL.Eukaryotic regulatory RNAs: an answer to the genome complexity conundrum. Genes and Development. 2007; 21: 11–42.</mixed-citation><mixed-citation xml:lang="en">Prasanth KV, Spector DL. Eukaryotic regulatory RNAs: an answer to the genome complexity conundrum. Genes and Development. 2007; 21: 11–42.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are: conserved targets of microRNAs. Genome Res. 2009 Jan; 19 (1): 92–105. doi: 10.1101/gr.082701.108. Epub 2008 Oct 27.</mixed-citation><mixed-citation xml:lang="en">Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are: conserved targets of microRNAs. Genome Res. 2009 Jan; 19 (1): 92–105. doi: 10.1101/gr.082701.108. Epub 2008 Oct 27.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004 Jul; 5 (7): 522–531.</mixed-citation><mixed-citation xml:lang="en">He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004 Jul; 5 (7): 522–531.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Тишевская НВ, Геворкян НМ, Бабаева АГ, Захаров ЮМ и др. Влияние суммарной РНК лимфоидных клеток селезенки на эритропоэз при экспериментальной полицитемии. Российский физиол. журнал им. И.М. Сеченова. 2015; 101 (4): 451–461.</mixed-citation><mixed-citation xml:lang="en">Tishevskaya NV, Gevorkyan NM, Babaeva AG, Zaharov YuM et al. The influence of the total mRNA of lymphoid cells of the spleen on erythropoiesis at experimental polycythemia. Rossijskij fiziol. zhurnal im I.M. Sechenova. 2015; 101 (4): 451–456.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Бабаева АГ, Геворкян НМ, Тишевская НВ, Головкина ЛЛ и др. О гемопоэтических свойствах рибонуклеиновой кислоты лимфоцитов периферической крови больных истинной полицитемией и здоровых доноров. Онкогематология. 2015; 2 (10): 58–62.</mixed-citation><mixed-citation xml:lang="en">Babaeva AG, Gevorkyan NM, Tishevskaya NV, Golovkina LL et al. About hematopoietic properties of ribonucleic acid of peripheral blood lymphocytes of patients with true polycythemia and healthy donors. Oncogematologiya. 2015; 2 (10): 58–62.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Онищенко НА. Цитогенетическая рекапитуляция, индуцированная медикаментозными препаратами, как универсальный этап формирования срочной защиты органов от повреждения при трансплантации. Патологическая физиология и экспериментальная терапия. 2016; 60 (4): 148–153.</mixed-citation><mixed-citation xml:lang="en">Onishchenko NA. Cytogenetic recapitulation, induced by medical preparations, as the universal stage of formation of urgent protection against damage at organ transplantation. Patologicheskaya fiziologiya i eksperimental’naya terapiya. 2016; 60 (4): 148–153.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
